INTERVIEW: PT talks diabetes with AZ’ Chris Boulton
PharmaTimes Digital talks to Chris Boulton, Director of Marketing at AstraZeneca, about diabetes and what the drugs giant is doing to improve treatment outcomes.
Read MoreSearch Results for: Chris Ross
Aesica has appointed Chris Gowland to the Board
As Group Chief Operating Officer, Gowland will further enhance operational performance of all API...
Read MoreAZ compound christens Cancer Development Partnerships programme
A compound from AstraZeneca in the same chemical class as Novartis’ Glivec (imatinib) and Roche’s Tarceva (erlotnib) is the first drug candidate to enter Cancer Research UK’s Clinical Development Partnerships (CDP) programme.
Read More
UK cancer centre to offer breast cancer treatment at home
The Christie NHS Foundation Trust will offer the breast cancer treatment Phesgo to patients in their own homes
Read More- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
- Study finds mechanical changes in tumour tissue offer new insights for cancer research
- Cambridge study finds AI more accurately assesses eye problems compared to doctors
